{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:28:28Z","timestamp":1761744508417},"reference-count":28,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/br.2017.907","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T07:39:44Z","timestamp":1494315584000},"page":"595-598","source":"Crossref","is-referenced-by-count":4,"title":["Involvement of glycogen debranching enzyme in bladder cancer"],"prefix":"10.3892","volume":"6","author":[{"given":"Benjamin","family":"Weinhaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunny","family":"Guin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"key20180107142920_b1-br-0-0-907","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"key20180107142920_b2-br-0-0-907","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156802606776173483","article-title":"Estrogen receptors as therapeutic targets in breast cancer","volume":"6","author":"Ariazi","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"key20180107142920_b3-br-0-0-907","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.21037\/jtd.2016.11.46","article-title":"Precision medicine in lung cancer: The battle continues","volume":"8","author":"Waqar","year":"2016","journal-title":"J Thorac Dis"},{"key":"key20180107142920_b4-br-0-0-907","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107142920_b5-br-0-0-907","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"PROFILE 1014 Investigators: First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N Engl J Med"},{"key":"key20180107142920_b6-br-0-0-907","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key20180107142920_b7-br-0-0-907","doi-asserted-by":"crossref","first-page":"82567","DOI":"10.18632\/oncotarget.12856","article-title":"Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: A network meta-analysis","volume":"7","author":"Zhuo","year":"2016","journal-title":"Oncotarget"},{"key":"key20180107142920_b8-br-0-0-907","journal-title":"A Snapshot of Bladder Cancer"},{"key":"key20180107142920_b9-br-0-0-907","doi-asserted-by":"crossref","first-page":"pii: dju062","DOI":"10.1093\/jnci\/dju062","article-title":"Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease","volume":"106","author":"Guin","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"key20180107142920_b10-br-0-0-907","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin"},{"key":"key20180107142920_b11-br-0-0-907","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet]","author":"Dagli"},{"key":"key20180107142920_b12-br-0-0-907","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrurol.2015.111","article-title":"Targeting glycogen metabolism in bladder cancer","volume":"12","author":"Lew","year":"2015","journal-title":"Nat Rev Urol"},{"key":"key20180107142920_b13-br-0-0-907","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1471-4159.2012.07646.x","article-title":"Serine hydroxymethyltransferase 1 and 2: Gene sequence variation and functional genomic characterization","volume":"120","author":"Hebbring","year":"2012","journal-title":"J Neurochem"},{"key":"key20180107142920_b14-br-0-0-907","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1218595","article-title":"Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation","volume":"336","author":"Jain","year":"2012","journal-title":"Science"},{"key":"key20180107142920_b15-br-0-0-907","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1078-0432.CCR-15-1706","article-title":"Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis","volume":"22","author":"Guin","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20180107142920_b16-br-0-0-907","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1734-1140(13)71465-8","article-title":"Hyaluronan: Towards novel anti-cancer therapeutics","volume":"65","author":"Karbownik","year":"2013","journal-title":"Pharmacol Rep"},{"key":"key20180107142920_b17-br-0-0-907","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1742-4658.2011.08070.x","article-title":"Transcriptional and post-translational regulation of hyaluronan synthesis","volume":"278","author":"Tammi","year":"2011","journal-title":"FEBS J"},{"key":"key20180107142920_b18-br-0-0-907","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1742-4658.2011.08069.x","article-title":"Hyaluronan matrices in pathobiological processes","volume":"278","author":"Wang","year":"2011","journal-title":"FEBS J"},{"key":"key20180107142920_b19-br-0-0-907","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-12-800092-2.00002-2","article-title":"Targeting hyaluronic acid family for cancer chemoprevention and therapy","volume":"123","author":"Lokeshwar","year":"2014","journal-title":"Adv Cancer Res"},{"key":"key20180107142920_b20-br-0-0-907","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2015.00123","article-title":"4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer","volume":"6","author":"Nagy","year":"2015","journal-title":"Front Immunol"},{"key":"key20180107142920_b21-br-0-0-907","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/1567201813666151109103013","article-title":"Hyaluronan\/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer","volume":"13","author":"Nikitovic","year":"2016","journal-title":"Curr Drug Deliv"},{"key":"key20180107142920_b22-br-0-0-907","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.actbio.2013.12.019","article-title":"Hyaluronan: A simple polysaccharide with diverse biological functions","volume":"10","author":"Dicker","year":"2014","journal-title":"Acta Biomater"},{"key":"key20180107142920_b23-br-0-0-907","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fimmu.2015.00154","article-title":"CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis","volume":"6","author":"Orian-Rousseau","year":"2015","journal-title":"Front Immunol"},{"key":"key20180107142920_b24-br-0-0-907","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front Immunol"},{"key":"key20180107142920_b25-br-0-0-907","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1242\/jcs.022038","article-title":"Cell-surface and mitotic-spindle RHAMM: Moonlighting or dual oncogenic functions?","volume":"121","author":"Maxwell","year":"2008","journal-title":"J Cell Sci"},{"key":"key20180107142920_b26-br-0-0-907","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/0008-5472.CAN-09-3185","article-title":"Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells","volume":"70","author":"Lokeshwar","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107142920_b27-br-0-0-907","doi-asserted-by":"crossref","first-page":"djv085","DOI":"10.1093\/jnci\/djv085","article-title":"Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer","volume":"107","author":"Yates","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"key20180107142920_b28-br-0-0-907","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12885-016-2756-5","article-title":"CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)","volume":"16","author":"Oldenburg","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:43:14Z","timestamp":1719189794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,5,9]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/br.2017.907"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.907","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}